Treatment of Hidradenitis Suppurativa in 2021 & Beyond
At the ODAC 2021 Sneak Peek Symposium on Inflammatory Skin Diseases, expert faculty presented on the topics of acne, rosacea, atopic dermatitis, hidradenitis suppurativa, and psoriasis. If you missed the live symposium, Next Steps will be sharing highlights and a summary of each lecture over the course of the next few weeks. Today, Dr. Blari Allais shares an excellent recap of Dr. Joslyn Kirby's s …
At the ODAC 2021 Sneak Peek Symposium on Inflammatory Skin Diseases, expert faculty presented on the topics of acne, rosacea, atopic dermatitis, hidradenitis suppurativa, and psoriasis. If you missed the live symposium, Next Steps will be sharing highlights and a summary of each lecture over the course of the next few weeks. Today, Dr. Blari Allais shares an excellent recap of Dr. Joslyn Kirby's s … Continue reading "Treatment of Hidradenitis Suppurativa in 2021 & Beyond"
The following is a summary of one of the many Q&A sessions held during the 2020 Skin of Color Virtual Update. During this particular session, questions were moderated by SOCU Co-Chair Dr. Andrew Alexis and answered by Drs. Ginette Okoye and Candrice Heath. The audience posed important questions and the faculty offered insightful answers regarding atopic dermatitis, hidradenitis suppurativa, h … 
With the advent of biologics, patients with moderate-to-severe plaque psoriasis have experienced increased control of disease and improved quality of life. Tumor necrosis factor (TNF) inhibitors are some of the earliest biologics prescribed for psoriasis, psoriatic arthritis and, more recently, hidradenitis suppurativa. In this month’s installment of Therapeutic Cheat Sheets, we discuss TNF inhi … 
Next Steps in Derm author, Dr. Anna Chacon, searched the journals so that you don’t have to! She reports on important take-aways from different dermatology journals for the months of April, May, and June of 2019.
It is key to keep in mind that “important” is subjective and what is contained in this review is one person’s view of what should be remembered from these months of the literat … 
JDD authors Atrin Toussi BS BA, Stephanie T. Le MD, Virgina R. Barton MD, Chelsea Ma MD, Michelle Y. Cheng MD, Andrea Sukhov MD, Reason Wilken MD, Forum Patel MD, Elizabeth Wang MD, and Emanual Maverakis MD present a case of a 60-year-old woman with recalcitrant pyoderma gangrenosum treated with adalimumab, who paradoxically developed psoriasis.
Introduction
Pyoderma gangrenosum (PG) is … 